DelveInsight's automated suturing devices research report - forecast till 2030 highlights that the global automated suturing devices market is on a steady growth trajectory, driven by rising surgical volumes, an aging population, and increasing chronic disease burden. The market, valued at USD 2.53 billion in 2023, is projected to grow at a CAGR of 6.81% between 2024 and 2030, reaching an estimated USD 3.74 billion by the end of the forecast period.
An automatic suture device is designed to simplify and speed up wound and tissue closure during surgical procedures, reducing operator dependency and procedure time compared to manual suturing. As hospitals and ambulatory centers increasingly prioritize efficiency and consistency in the operating room, adoption of the automated suturing device category continues to gain momentum across cardiovascular, gynecological, gastrointestinal, and orthopedic applications.
Automatic suture device Market Drivers
The rising global burden of cancer is among the most significant drivers of the automated suturing devices market. According to the World Health Organization, 2022, breast cancer accounted for nearly 2.26 million new cases in 2020, followed closely by lung cancer, colorectal cancer, and prostate cancer. As cancer incidence climbs, the corresponding volume of surgical interventions rises, directly boosting demand for reliable suturing technologies.
Trauma and injury statistics further reinforce this trend. WHO 2022 data indicates that between 20 and 50 million people suffer non-fatal injuries annually, many resulting in long-term disability. The International Labour Organization similarly reports around 340 million occupational accidents each year worldwide. Each of these events contributes to greater demand for surgical closure solutions, including the automatic suture device segment.
Regulatory approvals are also accelerating uptake. Devices such as Endomina, developed by Endo Tools Therapeutics, received FDA approval in January 2022 for endoscopic suture placement in the gastrointestinal tract, while Anchora Medical's Su2ura Approximation Device secured 510(k) clearance in July 2021 for laparoscopic soft tissue suturing. These milestones reflect a maturing regulatory pathway that is expected to support continued innovation through 2030.
Automatic suture device Market Restraints
Despite favorable growth drivers, the market faces headwinds including limited product availability, a shortage of trained professionals capable of operating advanced suturing systems, and the relatively high cost of automated devices compared to conventional alternatives. The COVID-19 pandemic also temporarily slowed elective and non-emergency surgical volumes, though the market has since resumed its upward trajectory alongside broader healthcare recovery.
Segment and Regional Insights
By application, the gynecological segment is expected to hold a significant revenue share. WHO 2022 data notes cervical cancer as the fourth most common cancer among women globally, with roughly 604,000 new cases recorded in 2020, while ovarian and endometrial cancers each contribute hundreds of thousands of additional cases annually. This has meaningful implications for the broader gynecology suture market, as rising procedure volumes in this specialty continue to support device demand.
Geographically, North America is projected to dominate the us automated suturing devices market throughout the forecast period. Supporting factors include over 13 million surgical procedures performed in the United States between January 2019 and January 2021 (WHO 2021), nearly 55.4 million motor-vehicle-related injuries reported in 2020, and CDC data showing that six in ten U.S. adults live with at least one chronic condition. Collectively, these trends are expected to sustain strong momentum in the us wound closure devices market as well.
Key companies operating in this space include Medtronic, LSI Solutions, Sutrue Limited, Apollo Endosurgery, B. Braun Melsungen AG, Becton, Dickinson & Company, Ethicon (Johnson & Johnson), Smith & Nephew, EndoEvolution, Mellon Medical B.V., Endo Tools Therapeutics, EDGe Surgical, Medical Microinstruments, and SuturTek, among others.
Automatic suture device Market Outlook
With increasing regulatory clearances, growing procedural volumes, and technological refinement, the automated suturing devices market is poised for consistent expansion through 2030. Stakeholders across the value chain — from manufacturers to healthcare providers — stand to benefit from continued investment in this space.
For deeper insights into related segments, explore DelveInsight's coverage of the endoluminal suturing devices market, united states surgical sutures market, suture anchor device market, and cardiac sutures market, each offering targeted analysis of adjacent opportunities within the broader wound closure and surgical device landscape.
Latest Reports Offered by Delveinsight
gaucher disease market | metastatic castration resistant prostate cancer ma | post operative pain market | rheumatoid arthritis market | rhinosinusitis market | skin grafting devices market | small cell lung cancer market | synchronous endometrial and ovarian carcinoma n | advanced liver cancer market | age-related macular degeneration market | alagille syndrome market | atypical teratoid rhabdoid tumors market | balloon catheters market | bradycardia treatment devices market | cardiac arrhythmia monitoring devices market | cardiac implantable electronic devices market | cardiac output monitor market | chronic idiopathic constipation market | chronic neuropathic pain market | diabetic wound market | dry amd market | fallopian tube cancer market | germany healthcare outlook |
About Delveinsight
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Contact Us
Kanishk